- Rebates are a huge worldwide business - Rebate Delivery is the first global rebate service for online sales, operating the consumer portal GetMyRebate.com Further inquiry note: Kirsten Neininger Corporate Marketing Manager Telefon: +49 (0) 721 96 458 6399 e-mail: kirsten.neininger@asknet.de Branche: Electronic ...
Further inquiry note: Verena Fehling Investor Relations Telefon: +49(0)4102 463-100 E-Mail: Verena.Fehling@baslerweb.com Branche: Semiconductors & active components ISIN: DE0005102008 WKN: 510200 Index: CDAX Börsen: Frankfurt / regulated dealing/prime standard Berlin / free trade Hamburg / free trade Stuttgart / free trade Düsseldorf / free trade München / free trade ...
Further inquiry note: Dr. Bernhard Matzner Chief Financial Officer/FACC AG Tel. 059-616-1324 b.matzner@facc.at Branche: Industrial Components ISIN: AT0000A05TW8 WKN: Börsen: Wien / Regulated free trade ...
Ingelheim, Germany, November 16 (ots/PRNewswire) - - Results Support Flibanserin as a Potential Treatment for HSDD, an Under-Recognised Women's Sexual Health Condition - For Medical Media, Outside the US Only Data from pooled, pivotal Phase III clinical trials demonstrate that flibanserin 100mg taken once daily at ...
Further inquiry note: Branche: Oil & Gas - Downstream activities ISIN: AT0000743059 WKN: 874341 Index: ATX Prime, ATX Börsen: Wien / official dealing ...
Further inquiry note: For further information, please contact: ElringKlinger AG Investor Relations / Corporate Communications Stephan Haas Max-Eyth-Straße 2 72581 Dettingen Phone: +49 0 7123-724-137 E-mail: stephan.haas@elringklinger.de Branche: Automotive Equipment ISIN: DE0007856023 WKN: 785602 Index: MDAX, Classic All Share, Prime All Share Börsen: Frankfurt / ...
Ingelheim, Germany (ots/PRNewswire) - - New Formulation Brings the Established Efficacy of Mirapexin(R)/Sifrol(R) to Patients With Parkinson's Disease in the Convenience of a Once Daily Dose Boehringer Ingelheim today announced that the Mirapexin(R)/Sifrol(R) (pramipexole) new prolonged-release , once daily tablet ...
Further inquiry note: For further information, please contact: ElringKlinger AG Corporate Communications Max-Eyth-Straße 2, 72581 Dettingen / Erms Phone: +49 (0)7123-724-640 / 137 Fax: +49 (0)7123-724-641 E-mail: stephan.haas@elringklinger.de karl-heinz.app@elringklinger.de Branche: Automotive Equipment ISIN: DE0007856023 WKN: 785602 Index: MDAX, Classic All Share, ...
Further inquiry note: Branche: Oil & Gas - Downstream activities ISIN: AT0000743059 WKN: 874341 Index: ATX Prime, ATX Börsen: Wien / official dealing ...
Cape Town, South Africa (ots/PRNewswire) - - For Medical Media Outside the US Only Results from the ARTEN* trial presented at the 5th International AIDS Society (IAS) conference in Cape Town, South Africa demonstrated non-inferiority regarding efficacy between Viramune(R) (nevirapine) and ritonavir boosted ...
- CONCENTRATION OF INDIVIDUAL WAFER DIAMETERS AT LEAD SITES AND STRUCTURAL IMPROVEMENTS AT WACKER SILICONES - IMPAIRMENTS OF SOME 120 MILLION AT SILTRONIC, EXPECTED REDUCTION OF NEARLY 800 JOBS AT SILTRONIC AND WACKER SILICONES BY END OF 2010 - CONTROL AND PROFIT TRANSFER AGREEMENT BETWEEN SILTRONIC AND WACKER REDUCES TAX RATE - PERSONNEL DIRECTOR SITTENTHALER: I SEE A GOOD CHANCE OF IMPLEMENTING THE PLANNED JOB CUTS ...
Further inquiry note: Joerg Hoffmann Investor Relations Tel.: +49 (0)89 6279 1633 E-Mail: joerg.hoffmann@wacker.com Branche: Chemicals ISIN: DE000WCH8881 WKN: WCH888 Index: Midcap Market Index, MDAX, CDAX, Classic All Share, HDAX, Prime All Share Börsen: Frankfurt / regulated dealing/prime standard ...
Ingelheim, Germany (ots/PRNewswire) - - For Medical Media Outside the US only Boehringer Ingelheim announced today that the European Commission has approved an update of the Summary of Product Characteristics (SmPC) for VIRAMUNE(R) (nevirapine) in the treatment of patients with HIV. The decision followed a positive recommendation by the Committee for Medical Products ...
Ingelheim, Germany (ots/PRNewswire) - - For non-U.S. Healthcare Media Boehringer Ingelheim announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMEA) has issued a positive opinion recommending the approval of a once daily formulation for Mirapexin(R) / ...
Ingelheim, Germany (ots/PRNewswire) - - Results From Linagliptin Study in Type 2 Diabetes Patients Who Were Inadequately Controlled on Metformin Therapy Alone, Presented at Major Diabetes Meeting Study results presented for the first time in the scientific sessions of this year's American Diabetes Association Annual ...
Ingelheim, Germany (ots/PRNewswire) - - New Study Shows That Mirapexin(R)/Sifrol(R) (Pramipexole) Relieves Depressive Symptoms of Parkinson's Disease (PD), a Common Non-Motor Symptom Affecting PD Patients' Quality of Life - For Non-US Healthcare Media To view the Multimedia News Release, go to: ...
Ingelheim, Germany (ots/PRNewswire) - - Data for the Once Daily Mirapexin(R)/Sifrol(R) (Pramipexole) Formulation Under Development Show Efficacy, Safety and Tolerability Outcomes Comparable to the Current Immediate Release Formulation for the Treatment of Parkinson's Disease For non-US Healthcare Media First data ...
Ingelheim, Germany (ots/PRNewswire) - - For Healthcare Media outside the U.S.A. New data presented today at the 61st Annual Meeting of the American Academy of Neurology (AAN), in Seattle, U.S.A. show that augmentation did not significantly differ in RLS patients treated with Mirapexin(R) /Sifrol(R) (pramipexole*) ...
Atrium European Real Estate Limited
Further inquiry note: Financial Dynamics: +44 (0)20 7831 3113 Richard Sunderland Laurence Jones Richard.sunderland@fd.com Branche: Real Estate ISIN: AT0000660659 WKN: 066065 Index: Standard Market Continous Börsen: Wiener Börse AG / official market ...
Ingelheim, Germany (ots/PRNewswire) - - ESO Recommends Extended Time Window for Actilyse(R) INGELHEIM, Germany, January 30 /PRNewswire/ -- - For Healthcare Media outside the U.S.A., Canada, and Japan Based on key results from the European Cooperative Acute Stroke Study (ECASS 3), the European Stroke Organisation (ESO) now recommends that Actilyse(R) (alteplase) be ...
Ingelheim, Germany, November 17 (ots/PRNewswire) - - Progress Continues Across Expanding Oncology Pipeline With Two Compounds now in Phase III Clinical Development and a Potential First-in-Class Polo-Like Kinase 1 Inhibitor Soon to Enter Phase II - For non-US Healthcare Media Boehringer Ingelheim has marked a new ...
Further inquiry note: Branche: Oil & Gas - Downstream activities ISIN: AT0000743059 WKN: 874341 Index: ATX Prime, ATX Börsen: Wiener Börse AG / official dealing ...
Beijing (ots/PRNewswire) - New results from the landmark ONTARGET(R) Trial show that, in Asian patients at high risk of cardiovascular disease (CVD), telmisartan (MICARDIS(R)) 80mg is as effective as, and significantly better tolerated than, ramipril 10mg in reducing the risk of cardiovascular death, heart attack, ...
Ingelheim and Biberach, Germany (ots/PRNewswire) - - Boehringer Ingelheim Oncology Pipeline Advances: Two Leading Compounds are Entering Phase III Trials - Boehringer Ingelheim's Investigational Compound in Development for the Treatment of Pre-Menopausal Women Suffering From Hypoactive Sexual Desire Disorder (HSDD) ...
Ingelheim, Germany (ots/PRNewswire) - - For Healthcare Media Outside the U.S.A., Canada, and Japan - Favourable Safety and Efficacy Profile of Actilyse(R) Confirmed by ECASS 3 Study Investigating Treatment in an Extended Time Window up to 4.5 Hours After Symptom Onset First results from ECASS 3 (European Cooperative ...
Felix Zimmermann to become sole CEO of power supply and charger manufacturer -Lonng-term Chairman and CEO Rolf Endress and CFO Frank Gumbinger leave the company by mutual consent Change due to new size and focus of CEAG Further inquiry note: Gudrun Richter Investor Relations Telefon: +49 (0) 2532-81-158 E-Mail: richter@friwo.de Branche: Semiconductors & active components ISIN: DE0006201106 WKN: 620110 Index: CDAX ...
Ludwigshafen (ots) - In this podcast you will learn how organic photovoltaics helps to produce solar cells with completely new qualities. In organic photovoltaics dyes are used that are able to convert light into electrical energy. Due to the extremely thin photovoltaic layer, flexible or even ...
Munich, Germany (ots/PRNewswire) - - TRANSCEND(R), Parallel Trial to ONTARGET(R), Confirms Long-Term Protective Benefits and Excellent Tolerability Profile of Telmisartan 80mg(1) on Top of Current Best Standard of Care MUNICH, Germany, August 31 /PRNewswire/ -- - For non-US Healthcare Media The results of the ...
Ludwigshafen (ots) - In this podcast you will learn how the unique characteristics of liquid salts make ionic liquids so interesting for industry. Ionic liquids are molten salts that are also in a liquid form at room temperature. The unique characteristics of these liquid salts are the very thing that makes ionic liquids so interesting for ...
Further inquiry note: Hannes Roither, PALFINGER AG Company Spokesperson Phone +43 662 46 84-2260 mailto: h.roither@palfinger.com www.palfinger.com Branche: Machine Manufacturing ISIN: AT0000758305 WKN: 919964 Index: ATX Prime, ATX Börsen: Wiener Börse AG / official market ...
